Physician profile
Julia Bartossik
NPI 1811217359
$1,038.72
in general payments reported to CMS, 2019-2025
12 companies · $92.03 in 2025
The $92.03 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $398 · 2022: $264 · 2023: $93.79 · 2024: $191 · 2025: $92.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $227.80 | 2024-2025 | Otezla, Repatha, Otezla |
| Amarin Pharma, INC. | $216.73 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $125.00 | 2021 | |
| Abbvie INC. | $123.57 | 2021-2025 | |
| Horizon Therapeutics Plc | $118.55 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.21 | 2023-2024 | Xifaxan, Trulance |
| E.R. Squibb & Sons, L.L.C. | $47.11 | 2021 | |
| Lilly USA, LLC | $45.01 | 2022-2023 | Mounjaro |
| Vistapharm, INC. | $28.34 | 2021 | |
| Shield Therapeutics INC | $23.69 | 2024 | |
| Nestle Healthcare Nutrition INC. | $19.83 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Bartossik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.